BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35107367)

  • 1. Prognostic significance of Naples prognostic score in non-small-cell lung cancer patients with brain metastases.
    Xuan J; Peng J; Wang S; Cai Y
    Future Oncol; 2022 Apr; 18(13):1545-1555. PubMed ID: 35107367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naples Prognostic Score as a novel prognostic prediction tool in video-assisted thoracoscopic surgery for early-stage lung cancer: a propensity score matching study.
    Li S; Wang H; Yang Z; Zhao L; Lv W; Du H; Che G; Liu L
    Surg Endosc; 2021 Jul; 35(7):3679-3697. PubMed ID: 32748268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer.
    Peng SM; Ren JJ; Yu N; Xu JY; Chen GC; Li X; Li DP; Yang J; Li ZN; Zhang YS; Qin LQ
    Sci Rep; 2022 Apr; 12(1):5782. PubMed ID: 35388133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Preoperative Naples Prognostic Score in Patients With Non-Small Cell Lung Cancer.
    Ren D; Wu W; Zhao Q; Zhang X; Duan G
    Technol Cancer Res Treat; 2022; 21():15330338221129447. PubMed ID: 36254549
    [No Abstract]   [Full Text] [Related]  

  • 5. Naples Prognostic Score as an Independent Predictor of Survival Outcomes for Resected Locally Advanced Non-Small Cell Lung Cancer Patients After Neoadjuvant Treatment.
    Zou Z; Li J; Ji X; Wang T; Chen Q; Liu Z; Ji S
    J Inflamm Res; 2023; 16():793-807. PubMed ID: 36860794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer.
    Guo D; Liu J; Li Y; Li C; Liu Q; Ji S; Zhu S
    J Inflamm Res; 2021; 14():6129-6141. PubMed ID: 34848991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
    Sperduto PW; Yang TJ; Beal K; Pan H; Brown PD; Bangdiwala A; Shanley R; Yeh N; Gaspar LE; Braunstein S; Sneed P; Boyle J; Kirkpatrick JP; Mak KS; Shih HA; Engelman A; Roberge D; Arvold ND; Alexander B; Awad MM; Contessa J; Chiang V; Hardie J; Ma D; Lou E; Sperduto W; Mehta MP
    JAMA Oncol; 2017 Jun; 3(6):827-831. PubMed ID: 27892978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
    Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
    Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
    Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
    Takamori S; Komiya T; Powell E
    Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy.
    Liu J; Wang Z; Liu G; Liu Z; Lu H; Ji S
    Ann Med; 2023; 55(2):2242254. PubMed ID: 37552770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic nutritional index and systemic immune-inflammation index are prognostic biomarkers for non-small-cell lung cancer brain metastases.
    Li W; Qu Y; Wen F; Yu R; He X; Jia H; Liu H; Yu H
    Biomark Med; 2021 Sep; 15(13):1071-1084. PubMed ID: 34397267
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of prognostic factors in NSCLC patients with brain metastases 
diagnosed by constrast-enhanced MRI after whole brain radiotherapy].
    Liu H; Wu Q; Gong X; He X; Wu H; Sheng Z; Zhou D
    Zhongguo Fei Ai Za Zhi; 2011 Sep; 14(9):719-22. PubMed ID: 21924038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.
    Enders F; Geisenberger C; Jungk C; Bermejo JL; Warta R; von Deimling A; Herold-Mende C; Unterberg A
    Clin Neurol Neurosurg; 2016 Mar; 142():72-80. PubMed ID: 26816105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
    She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
    Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery.
    Gao HX; Huang SG; Du JF; Zhang XC; Jiang N; Kang WX; Mao J; Zhao Q
    Int J Biol Sci; 2018; 14(14):2065-2072. PubMed ID: 30585269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.